Literature DB >> 6555219

Different rates of synthesis and turnover of ribosomal RNA in rat brain and liver.

A S Stoykova, K P Dudov, M D Dabeva, A A Hadjiolov.   

Abstract

The kinetics of in vivo labeling of cellular free UMP and nucleolar, nucleoplasmic, and cytoplasmic rRNA with [14C]orotate in rat brain and liver were investigated. Evaluation of the experimental data shows: (a) The rate of nucleolar precursors of ribosomal RNA (pre-rRNA) synthesis and the deduced rate of ribosome formation in brain is about fivefold lower than in liver and corresponds to 220-260 ribosomes/min/nucleus. (b) The lower rate of in vivo pre-rRNA synthesis is correlated with a lower activity of RNA polymerase I in isolated brain nuclei. (c) The half-lives of nucleolar rRNA in brain and liver are 210 and 60 min, respectively, thus showing a slower rate of processing of pre-rRNA in brain nucleoli. (d) The nucleo-cytoplasmic transport of ribosomes in brain is also markedly slower than in liver and reflects the lower rates of synthesis and processing of pre-rRNA. (e) Cytoplasmic ribosomes in brain and liver turn over with half-lives of about 6 and 4 days, respectively. It is concluded that the markedly lower rate of ribosome biogenesis in brain is specified mainly at the level of transcription of rRNA genes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6555219     DOI: 10.1111/j.1471-4159.1983.tb09038.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  RNA polymerase 1-driven transcription as a mediator of BDNF-induced neurite outgrowth.

Authors:  Cynthia Gomes; Scott C Smith; Mark N Youssef; Jing-Juan Zheng; Theo Hagg; Michal Hetman
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

Review 2.  Emerging roles of the neuronal nucleolus.

Authors:  Michal Hetman; Maciej Pietrzak
Journal:  Trends Neurosci       Date:  2012-02-02       Impact factor: 13.837

3.  Nucleolar Enrichment of Brain Proteins with Critical Roles in Human Neurodevelopment.

Authors:  Lukasz P Slomnicki; Agata Malinowska; Michal Kistowski; Antoni Palusinski; Jing-Juan Zheng; Mari Sepp; Tonis Timmusk; Michal Dadlez; Michal Hetman
Journal:  Mol Cell Proteomics       Date:  2016-04-06       Impact factor: 5.911

4.  Requirement of Neuronal Ribosome Synthesis for Growth and Maintenance of the Dendritic Tree.

Authors:  Lukasz P Slomnicki; Maciej Pietrzak; Aruna Vashishta; James Jones; Nicholas Lynch; Shane Elliot; Eric Poulos; David Malicote; Bridgit E Morris; Justin Hallgren; Michal Hetman
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

Review 5.  Neurotoxic mechanisms of DNA damage: focus on transcriptional inhibition.

Authors:  Michal Hetman; Aruna Vashishta; Grzegorz Rempala
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

Review 6.  Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies.

Authors:  Michal Hetman; Lukasz P Slomnicki
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

Review 7.  DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors.

Authors:  Edward C Gilmore
Journal:  Neurogenetics       Date:  2014-07-20       Impact factor: 2.660

8.  Labeling of heterochronic ribosomes reveals C1ORF109 and SPATA5 control a late step in human ribosome assembly.

Authors:  Chunyang Ni; Daniel A Schmitz; Jeon Lee; Krzysztof Pawłowski; Jun Wu; Michael Buszczak
Journal:  Cell Rep       Date:  2022-03-29       Impact factor: 9.423

9.  Expression of distinct maternal and somatic 5.8S, 18S, and 28S rRNA types during zebrafish development.

Authors:  Mauro D Locati; Johanna F B Pagano; Geneviève Girard; Wim A Ensink; Marina van Olst; Selina van Leeuwen; Ulrike Nehrdich; Herman P Spaink; Han Rauwerda; Martijs J Jonker; Rob J Dekker; Timo M Breit
Journal:  RNA       Date:  2017-05-12       Impact factor: 4.942

Review 10.  The Ribosome Biogenesis-Cancer Connection.

Authors:  Marianna Penzo; Lorenzo Montanaro; Davide Treré; Massimo Derenzini
Journal:  Cells       Date:  2019-01-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.